Company / Operating Margin
Adaptive Biotechnologies Corp Operating Margin History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-20.6%
FY2025
5-year range
-135.4% / -20.6%
FY2021-FY2025
Trend
+77.3%
vs FY2024
Sector context
#67 of 135
Health Care
What the data says
At -20.6%, Adaptive Biotechnologies Corp's operating margin ranks #67 of 135 in the Health Care sector. Operating Margin has fluctuated over the past 8 years, ranging from -155.3% in FY2020 to -20.6% in FY2025.
Based on SEC 10-K filings.
-20.6% in FY2025 with a 5-year CAGR of +134.7%.
Improved from -133.3% to -20.6% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- +87.4pp
- 5-Year Change
- +134.7pp
- 10-Year Change
- -
Sector benchmark
#67 of 135 in Health CareTop 50% of 135This company -20.6% Sector average -774.4%
▼
+97.3% above sector average
Key checks
Key Insights
- In FY2025, operating margin increased 77.3% year-over-year.
- Currently 753.8pp above the Health Care sector average.
- Lowest operating margin in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -1.45 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -20.6% | +77.3% |
| FY2024 | -90.8% | +31.9% |
| FY2023 | -133.3% | -23.4% |
| FY2022 | -108.0% | +20.2% |
| FY2021 | -135.4% | +12.8% |
| FY2020 | -155.3% | -68.6% |
| FY2019 | -92.2% | -3.1% |
| FY2018 | -89.4% | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026